Amneal Pharmaceuticals, Inc. AMRX Specialty — Other Operating Income
Other segment segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Amneal Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OtherOperatingIncomeExpenseNet.
The official record: Amneal Pharmaceuticals, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Amneal Pharmaceuticals, Inc.'s specialty — other operating income.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Amneal Pharmaceuticals, Inc.'s specialty — other operating income?
- Amneal Pharmaceuticals, Inc. (AMRX) reported specialty — other operating income of $0 in Q1 2026.
- What does specialty — other operating income mean?
- Captures miscellaneous operating income or expenses that do not fit into standard categories like cost of goods sold or R&D. It provides visibility into peripheral business activities and non-core operational fluctuations within the specialty segment.